Cyclophosphamide (CTX)
Cyclophosphamide (CTX) is a pharmaceutical drug with 16 clinical trials. Currently 7 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
4
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
7
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Rapid dFLC Response Predict CHR in AL Amyloidosis
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)
Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
Clinical Trials (16)
Rapid dFLC Response Predict CHR in AL Amyloidosis
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)
Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors
Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation
Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation
Non-Myeloablative Conditioning and Bone Marrow Transplantation
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis
A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome
Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage
All 16 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 16